Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:48 UTC |
---|
HMDB ID | HMDB0014965 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Cinoxacin |
---|
Description | Cinoxacin, also known as CINX or cinobac, belongs to the class of organic compounds known as cinnolines. These are organic aromatic compounds containing a benzene fused to a pyridazine ring. Within the most recent package insert (circa 1999) Cinobac is listed as being contraindicated in patients with a history of hypersensitivity to cinoxacin or other quinolones. Cinoxacin is a drug which is used for the treatment of initial and recurrent urinary tract infections in adults caused by the following susceptible microorganisms: escherichia coli, proteus mirabilis, proteus vulgaris, klebsiella species (including k. pneumoniae), and enterobacter species. There are reports that cinoxacin had also been used to treat initial and recurrent urinary tract infections and bacterial prostatitis in dogs. Cinoxacin is an extremely weak basic (essentially neutral) compound (based on its pKa). Relative to nalidixic acid, cinoxacin was found to have a slightly greater inhibitory and bactericidal activity. |
---|
Structure | CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12 InChI=1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17) |
---|
Synonyms | Value | Source |
---|
1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylic acid | ChEBI | 5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxa-5,6-diaza-cyclopenta[b]naphthalene-7-carboxylic acid | ChEBI | Cinoxacine | ChEBI | Cinoxacino | ChEBI | Cinoxacinum | ChEBI | CINX | Kegg | Cinobac | Kegg | 1-Ethyl-6,7-methylenedioxy-4(1H)-oxocinnoline-3-carboxylate | Generator | 5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxa-5,6-diaza-cyclopenta[b]naphthalene-7-carboxylate | Generator | 64716, Compound | HMDB | Azolinic acid | HMDB | Acid, azolinic | HMDB | Compound 64716 | HMDB | Clinoxacin | HMDB |
|
---|
Chemical Formula | C12H10N2O5 |
---|
Average Molecular Weight | 262.2182 |
---|
Monoisotopic Molecular Weight | 262.05897144 |
---|
IUPAC Name | 1-ethyl-4-oxo-1H,4H,7H-[1,3]dioxolo[4,5-g]cinnoline-3-carboxylic acid |
---|
Traditional Name | cinoxacin |
---|
CAS Registry Number | 28657-80-9 |
---|
SMILES | CCN1N=C(C(O)=O)C(=O)C2=CC3=C(OCO3)C=C12 |
---|
InChI Identifier | InChI=1S/C12H10N2O5/c1-2-14-7-4-9-8(18-5-19-9)3-6(7)11(15)10(13-14)12(16)17/h3-4H,2,5H2,1H3,(H,16,17) |
---|
InChI Key | VDUWPHTZYNWKRN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cinnolines. These are organic aromatic compounds containing a benzene fused to a pyridazine ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | Cinnolines |
---|
Alternative Parents | |
---|
Substituents | - Cinnoline
- Benzodioxole
- Pyridazine
- Benzenoid
- Heteroaromatic compound
- Vinylogous amide
- Oxacycle
- Azacycle
- Acetal
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Organic oxide
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 261 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.96 g/L | Not Available | LogP | 1.5 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Cinoxacin GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-0970000000-d6e7abdaf83ac6915d9c | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cinoxacin GC-MS (1 TMS) - 70eV, Positive | splash10-0006-4934000000-f98fd908e7ab28b030cf | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Cinoxacin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Cinoxacin LC-ESI-qTof , Positive-QTOF | splash10-00kr-2930000000-d8548621f53001ee222d | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Cinoxacin , positive-QTOF | splash10-00kr-2930000000-d8548621f53001ee222d | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 10V, Positive-QTOF | splash10-03di-0090000000-334244d6a89f0ca6b546 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 20V, Positive-QTOF | splash10-02ta-0190000000-4212f062c3b83386b041 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 40V, Positive-QTOF | splash10-0gi0-0890000000-25eee1869a982bf913fc | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 10V, Negative-QTOF | splash10-02t9-0290000000-79e8373fadc199462102 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 20V, Negative-QTOF | splash10-014i-0790000000-7942d2310d6730a23c27 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 40V, Negative-QTOF | splash10-03dl-1900000000-05b7716167bca8f2dd58 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 10V, Positive-QTOF | splash10-03di-0090000000-4fd0af9aad9b9655f431 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 20V, Positive-QTOF | splash10-0002-0090000000-4e532ea6a8a7a3dfc2f7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 40V, Positive-QTOF | splash10-03xr-1950000000-5d613602c0ff21ac9ab5 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 10V, Negative-QTOF | splash10-03xr-0090000000-4920e9eef443d07b78d7 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 20V, Negative-QTOF | splash10-000i-0920000000-9e4a8c05b0c3ecae8d01 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Cinoxacin 40V, Negative-QTOF | splash10-0909-0980000000-b400ebb127f6687745bf | 2021-10-11 | Wishart Lab | View Spectrum |
|
---|